China Digest: Newsonic Technologies, TransThera Sciences bag funding
TransThera sealed a $100m Series D round led by CPE and China Structural Reform Fund in July 2021.
Stay updated with breaking news from Transthera Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TransThera sealed a $100m Series D round led by CPE and China Structural Reform Fund in July 2021.
The global Biliary Tract Cancers (BTCs) treatment market is expected to witness steady growth in the coming years, according to a new report published by a leading market research firm. The report provides insights into the current market scenario, trends, drivers, challenges, and opportunities in the BTCs treatment...
The global Chloangiocarcinoma Therapeutics Market is predicted to generate a market value of US$ 800 million in 2023 and a market value of US$ 975.20 million by 2033, with a CAGR of 2% from 2023 to 2033. Changes in bile duct anatomy caused by inflammatory bowel illness, as well as exposure to certain toxins and poll...
During the forecast period 2023-2033, the Chloangiocarcinoma (CCA) Therapeutics market is expected to grow at a value of 2% CAGR, according to Future Market Insights. By the year 2033, the global market for Chloangiocarcinoma (CCA) Therapeutics is expected to rise up to a market valuation of US$ 975.20 Million. Grow...